MSLN and neoplasm: When the tumor volume reached 100 mm3, the mice were categorized into different treatment groups, each receiving one among cGAMP, NK-92 cells, cGAMP along with NK-92 cells and anti-MSLN CAR-NK-92 cells in combination with cGAMP (combination group).